1. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis.
- Author
-
Burastero, SE, Casali, P, Wilder, RL, and Notkins, AL
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Immunization ,Autoimmune Disease ,Arthritis ,Rheumatoid Arthritis ,Aetiology ,2.1 Biological and endogenous factors ,Inflammatory and immune system ,Adult ,Aged ,Antibody Affinity ,Antibody Specificity ,Antigens ,Differentiation ,B-Lymphocyte ,Arthritis ,Rheumatoid ,Autoantibodies ,B-Lymphocytes ,Cell Count ,Female ,Humans ,Immunoglobulin Fc Fragments ,Male ,Middle Aged ,Rheumatoid Factor ,Medical and Health Sciences ,Biomedical and clinical sciences ,Health sciences - Abstract
In patients with rheumatoid arthritis (RA), circulating CD5+ B lymphocytes, but not CD5- B lymphocytes, are increased in number and size, exist in an activated state, spontaneously proliferate, and secrete Ig that binds to the Fc fragment of IgG. By constructing continuous mAb-secreting cell lines from CD5+ B lymphocytes, the properties and dissociation constants (Kd) of these antibodies were determined. Two types of rheumatoid factors (RFs) with discrete reactivities were produced. The first type is polyreactive and binds with relatively low affinity (Kd, 10(-5) mol/liter) to the Fc fragment of IgG. These antibodies are similar to those produced by CD5+ B cells from healthy subjects. The second type of RF is monoreactive and binds with higher affinity (Kd, 10(-7) mol/liter) to the Fc fragment of IgG. These latter autoantibodies are produced by CD5+ B cells of RA patients, but not healthy subjects. Long-term longitudinal studies are needed to determine the role of these two types of RFs in the pathogenesis of RA.
- Published
- 1988